The 3D-printed products are indicated for posterior or transforaminal lumbar interbody fusion procedures in patients with degenerative disc disease.
The implants are the company’s first SPIRA products to enter the TLIF market, “the number one interbody market in the U.S. today,” Daniel Pontecorvo, Camber Spine co-founder and CEO, said in the release.
Mr. Pontecorvo said the company is looking to expand its reach in the TLIF market with a TLIF SPIRA cage product launch next year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
